Media-OutReach Newswire Constantly Strategical Planning High-Growth Sectors, Grand Pharma’s 2022 Interim Results Continue to Grow
Media-OutReach Newswire AsiaInfo Announces 2022 Interim Revenue up by 15% and New Orders up by Over 30%
Media-OutReach Newswire Grand Pharma Acquired 100% Equity of Hubei Bafeng, Further Expanding the Strategic Plan on High-quality Amino Acid Industry